- Home
- HUN vs OGN Comparison
HUN vs OGN Comparison
Compare HUN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUN
- OGN
- Stock Information
- Founded
- HUN 1970
- OGN 1923
- Country
- HUN United States
- OGN United States
- Employees
- HUN N/A
- OGN N/A
- Industry
- HUN Major Chemicals
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- HUN Industrials
- OGN Health Care
- Exchange
- HUN Nasdaq
- OGN Nasdaq
- Market Cap
- HUN 2.4B
- OGN 2.5B
- IPO Year
- HUN 2005
- OGN N/A
- Fundamental
- Price
- HUN $11.46
- OGN $9.93
- Analyst Decision
- HUN Hold
- OGN Hold
- Analyst Count
- HUN 9
- OGN 4
- Target Price
- HUN $14.28
- OGN $18.00
- AVG Volume (30 Days)
- HUN 4.2M
- OGN 3.7M
- Earning Date
- HUN 07-31-2025
- OGN 08-05-2025
- Dividend Yield
- HUN 8.42%
- OGN 0.80%
- EPS Growth
- HUN N/A
- OGN N/A
- EPS
- HUN N/A
- OGN 2.88
- Revenue
- HUN $5,976,000,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- HUN N/A
- OGN N/A
- Revenue Next Year
- HUN $5.22
- OGN $1.11
- P/E Ratio
- HUN N/A
- OGN $3.45
- Revenue Growth
- HUN 0.02
- OGN N/A
- 52 Week Low
- HUN $10.13
- OGN $8.01
- 52 Week High
- HUN $25.12
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- HUN 52.68
- OGN 51.13
- Support Level
- HUN $10.45
- OGN $9.71
- Resistance Level
- HUN $12.15
- OGN $10.27
- Average True Range (ATR)
- HUN 0.46
- OGN 0.37
- MACD
- HUN 0.17
- OGN 0.01
- Stochastic Oscillator
- HUN 65.59
- OGN 48.48
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.